Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Multiple Endocrinologic Complications in Thalassemia Major

  • Wong, Siong Hu (Department of Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia) ;
  • Omar, Julia (Department of Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia) ;
  • Ismail, Tuan Salwani Tuan (Department of Chemical Pathology, School of Medical Sciences, Universiti Sains Malaysia)
  • Received : 2017.07.17
  • Accepted : 2017.09.25
  • Published : 2017.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Thalassemia major is a genetic disorder with a defective synthesis of either the alpha or the beta chain of hemoglobin A. Blood transfusion is crucial for the survival in these patients. Unfortunately, endocrine dysfunction is a very common complication in these patients and is principally due to excessive iron overload as a result of frequent blood transfusions. Although regular blood transfusion may increase life expectancy, disturbances in growth and pubertal development, abnormal gonadal functions, impaired thyroid, parathyroid and adrenal functions, diabetes, and disorderly bone growth are common side effects. We hereby present a case of a 23-year-old, unmarried woman with beta thalassemia major presenting with primary amenorrhea, poor development of secondary sexual character, and short stature. Thorough history, clinical examination, and laboratory investigation, including dynamic function test (insulin tolerance test) were conducted. These tests confirmed that she had multiple endocrinopathies, including hypogonadotropic hypogonadism, growth hormone deficiency, and subclinical adrenal insufficiency, which were caused by iron overload. She required hormone replacement therapy. Early recognition of possible deficiencies in hypothalamo-pituitary-end organ hormones caused by iron overload in thalassemia patients that undergo frequent blood transfusion procedures is essential. Appropriate treatments, including transfusion regimen and chelation therapy, as well as specific treatment of each complication are the crucial for the successful management and improvement of quality of life these patients.

Keywords

References

  1. Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, et al. Metabolic and endocrinologic complications in beta thalassemia major: A muticentre study in Tehran. BMC Endocr Disord. 2003;3(1):4. http://dx.doi.org/10.1186/1472-6823-3-4
  2. Al-Elq AH, Al Sayeed HH. Endocrinopathies in patients with thalassemia. Saudi Med J. 2004; 25(10):1347-1351.
  3. De P, Mistry R, Wright C, Pancham S, Burbridge W, Gangopadhayay K, Pang T, Das G. A review of endocrine disorders in thalassaemia. Open J Endocr Metab Dis. 2014;4(2):25-34. https://doi.org/10.4236/ojemd.2014.42003
  4. Ang AL, Tzoulis P, Prescott E, Davis BA, Barnard M, Shah FT. History of myocardial iron loading is a strong risk factor for diabetes mellitus and hypogonadism in adult with beta thalassemia major. Eur J Haematol. 2014;92(3):229-236. https://doi.org/10.1111/ejh.12224
  5. PereraNJ, Lau NS, Mathews S, Waite C, Ho PJ, Caterson ID. Overview of endocrinopathies associated with beta-thalassemia major. Intern Med J. 2010;40(10):689-696. https://doi.org/10.1111/j.1445-5994.2010.02254.x
  6. Skordis N, Kyriakou A. The multifactorial origin of growth failure in thalassaemia. Pediatr Endocrinol Rev. 2011;(8 Suppl 2):271-277.
  7. Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among various thalassaemia syndromes in North America. Br J Haematol. 2009;146(5):546-556. https://doi.org/10.1111/j.1365-2141.2009.07793.x
  8. Scacchi M, Danesi L, Cattaneo A, Valassi E, PecoriGiraldi F, Argento C, et al. Growth hormone deficiency (GHD) in adult thalassaemic patients. Clin Endocrinol (Oxf). 2007;67(5):790-795. https://doi.org/10.1111/j.1365-2265.2007.02965.x
  9. Huang KE, Mittelman SD, Coates TD, Geffner ME, Wood JC. A significant proportion of thalassemia major patients have adrenal insufficiency detectable on provocative testing. J Pediatr Hematol Oncol. 2015;37(1):54-59. https://doi.org/10.1097/MPH.0000000000000199
  10. Poomthavorn P, Isaradisaikul B, Chuansumrit A, Mahachoklertwattana P, Sriphrapradang A, Khlairit P. High prevalence of "biochemical" adrenal insufficiency in thalassemics: Is it a matter of different testings or decreased cortisol binding globulin? J Clin Endocrinol Metab. 2010;95(10):4609-4615. https://doi.org/10.1210/jc.2010-0205
  11. Scacchi M, Danesi L, Cattaneo A, Valassi E, Giraldi FP, Radaelli P, et al. The pituitary-adrenal axis in adult thalassaemic patients. Eur J Endocrinol. 2010;162(1):43-48. https://doi.org/10.1530/EJE-09-0646
  12. De Sanctis V, Soliman AT, Elsedfy H, Skordis N, Kattamis C, Angastiniotis M, et al. Growth and endocrine disorders in thalassemia: The international network on endocrine complications in thalassemia (I-CET) position statement and guideline. Indian J Endocrinol Metab. 2013;17(1):8-18. https://doi.org/10.4103/2230-8210.107808